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Objective: The evaluation of operative mortality risk for cardiac surgery in infants
with low weight is limited. To determine whether low weight is a risk factor for
increased mortality, we reviewed the experience within the Society of Thoracic Sur-
geons Congenital Heart Surgery Database of infants who have undergone surgical
correction or palliation for congenital heart disease.
Methods: We analyzed mortality in 3022 infants ages 0 to 90 days weighing 1 to
2.5 kg (n 5 517) and greater than 2.5 to 4 kg (n 5 2505) who underwent cardiac
surgery from 2002 through 2004 at 32 participating centers. Patients were grouped
according to the primary procedure performed and analyzed according to their
weight at the time of surgical intervention. Patients were also analyzed according
to Risk Adjustment for Congenital Heart Surgery-1 and Aristotle Basic Complexity
scores.
Results: Compared with infants weighing 2.5 to 4 kg, infants weighing less than 2.5
kg had a significantly higher mortality for the following operations: repair of coarcta-
tion of the aorta, total anomalous pulmonary venous connection repair, arterial switch
procedure, systemic to pulmonary artery shunt, and the Norwood procedure. Lower
infant weight remained strongly associated with mortality risk after stratifying the
population by Risk Adjustment for Congenital Heart Surgery-1 levels 2 through 6
and Aristotle Basic Complexity levels 2 through 4.
Conclusions: Low weight at the time of surgical intervention is associated with
increased mortality in patients undergoing several types of cardiovascular procedures.
These data do not allow assessment of specific risks or benefits of any particular treat-
ment strategy. However, they do support the need for prospective analysis of specific
treatment strategies for these high-risk patients.
A
lthough outcomes for repair of congenital heart defects in neonates have
improved significantly over the last 10 years, low-weight infants remain
a challenging population. Despite recent single-institution reports1-5 of im-
proved survival in this difficult group, the significance of weight as a risk factor for
mortality remains unclear. Studies that report surgical outcomes in low-weight infants
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DAbbreviations and Acronyms
ABC 5 Aristotle Basic Complexity
CHD 5 congenital heart disease
PA/VSD 5 pulmonary atresia with ventricular septal
defect
RACHS-1 5 Risk Adjustment for Congenital Heart
Surgery 1
STS 5 Society of Thoracic Surgeons
TGA 5 transposition of the great arteries
have been limited to single institutions with limited numbers
of patients. These studies typically examine weight as an in-
dependent risk factor without including a comparison group
of normal-weight infants. In this study we used of the Society
of Thoracic Surgeons (STS) Congenital Heart Surgery Data-
base to evaluate the hypothesis that low-weight infants have
increased operative mortality when compared with children
of normal weight with similar defects.
Materials and Methods
Database
The STS Congenital Heart Surgery Database collects operative pro-
cedure-related data on neonates, infants, children, and adults under-
going operations for congenital heart anomalies. In 2004, 34
institutions contributed data to the congenital heart database. The
Duke Clinical Research Institute serves as the data collection and
management organization for all of the STS National Databases.
Data collected within the Congenital Heart Surgery Database
include basic demographic information, anatomic diagnosis, asso-
ciated noncardiac abnormalities, preoperative risk factors, intra-
operative details, surgical procedure performed, postoperative
complications, and operative mortality.
Study Population
Using the Congenital Heart Surgery Database, we analyzed mortal-
ity in infants up to 90 days of age who underwent cardiovascular
surgery between January 2002 and December 2004. Data from
participating centers with greater than 10% missing data for dis-
charge mortality or postoperative length of stay were excluded.
This left 18,253 patients from 32 centers with complete diagnosis
and procedure data for the first cardiovascular operation during their
index admission. From these, we excluded patients with age greater
than 90 days (n5 11,681), weight less than 1 kg or greater than 4 kg
(n5 1743), missing primary procedure data (n5 1760), or missing
discharge mortality status (n 5 47). The remaining patient popula-
tion for analysis was 3022.
Patients were further grouped according to primary cardiovascu-
lar diagnosis and procedures (Table 1). The primary procedure was
defined as the procedure with the highest Aristotle Basic Complex-
ity (ABC) score. If there were multiple procedures with equal com-
plexity scores listed, the procedure designated as the primary
procedure on the data collection form was used. Because the Risk
Adjustment for Congenital Heart Surgery 1 (RACHS-1) score was
not a required field in the database in 2004, this score was assigned
by the investigators.6The Journal of ThorStatistics
Patients were classified according to weight at the time of surgical
intervention: 1 to 2.5 kg (n 5 517) and greater than 2.5 to 4 kg
(n5 2505). Sex, ethnicity, and age were compared between patients
in each weight category (Table 2). Age was described as a median
and interquartile range (IQR; defined as 25th to 75th percentile),
and sex and ethnicity were described as frequencies. The distribu-
tion of age was compared by using a stratum-adjusted Wilcoxon
rank-sum test, although sex and ethnicity were compared by using
stratum-adjusted c2 tests. Mortality rates were calculated by weight
category for all combinations of diagnoses and procedures with
a sample size of at least 15. Relative risks and approximate 95% con-
fidence intervals were constructed to compare mortality risk
between groups. The hypothesis of no association between weight
group and mortality was assessed by using a c2 test. Identical anal-
yses were performed by using stratification with the RACHS-1
TABLE 1. Cardiac diagnoses
Cardiac anomaly n
Single ventricle 847
 Hypoplastic left heart syndrome (594)
 Tricuspid atresia (99)
 Double-inlet left ventricle (50)
 Unbalanced AVSD (17)
 Heterotaxy syndromes (34)
 Single ventricle, NOS (53)
TGA, intact ventricular septum 212
TGA, VSD 133
VSD 247
Truncus arteriosus 102
Total anomalous pulmonary venous connection 226
Tetralogy of Fallot 196
Pulmonary atresia, intact ventricular septum 128
Pulmonary atresia, VSD 137
Coarctation of aorta 594
Interrupted aortic arch 110
AVSD, Atrioventricular septal defect; NOS, not otherwise specified; TGA,
transposition of the great arteries; VSD, ventricular septal defect.
TABLE 2. Patient demographics
Characteristic
1–2.5 kg,
n 5 517 (%)
2.5–4.0 kg,
n 5 2505 (%) P value
Race
Other 47 (9.1) 198 (7.9) .19
Native American 1 (0.2) 9 (0.4)
Asian 11 (2.1) 55 (2.2)
Hispanic 74 (14.3) 416 (16.6)
Black 67 (13.0) 240 (9.6)
Caucasian 237 (45.8) 1236 (49.3)
Sex
Male 275 (53.2) 1446 (57.7) .07
Female 242 (46.8) 1,059 (42.3)
Age (d)
Median 9.00 (5.00–17.0) 7.00 (4.00–19.0) .34acic and Cardiovascular Surgery c Volume 135, Number 3 547
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DTABLE 3. Mortality data, diagnostic–procedure groups
Mortality rate,
overall (n 5 3022)
Mortality rate, 1–2.5 kg
(n 5 517)
Mortality rate 2.5–4 kg
(n 5 2505) Risk ratio (95% CI) P value*
Single ventricle
Norwood 22.4 (584) 30.0 (90) 21.1 (494) 1.43 (1.00–2.04) .03
Conduit/shunt 10.5 (191) 24.4 (45) 6.2 (146) 3.97 (1.76–8.96) ,.01
TGA/IVS
ASO 3.3 (212) 11.8 (17) 2.6 (195) 4.59 (0.96–21.90) .01
TAPVC
Repair 12.0 (226) 29.2 (24) 9.9 (202) 2.95 (1.39–6.23) .01
PA/VSD
Shunt 6.1 (99) 14.8 (27) 2.8 (72) 5.33 (1.04–27.46) .02
Coarctation
Arch repair 3.5 (594) 7.1 (112) 2.7 (482) 2.65 (1.12–6.24) ,.01
Single ventricle
Atrial septectomy 40 (20) 80.0 (5) 26.7 (15) 3.00 (1.16–7.73) .32
PA band 9.6 (52) 0 (9) 11.6 (43) NA .28
TGA/VSD
ASO 5.3 (133) 0 (17) 6.0 (116) NA .33
PA/VSD
Repair 7.9 (38) 12.5 (8) 6.7 (30) 1.88 (0.19–18.15) .39
PA/IVS
RVOT repair 5.6 (36) 0 (6) 6.7 (30) NA NA
Shunt palliation 15.2 (92) 22.7 (22) 12.9 (70) 1.77 (0.66–4.72) .48
VSD
Primary repair 1.7 (232) 8.0 (25) 1.0 (207) 8.28 (1.22–56.23) .33
PA band 0 (15) 0.0 (6) 0.0 (9) NA NA
AVSD
Primary repair 4.1 (73) 50.0 (2) 2.8 (71) 17.75 (2.54–124.28) .08
PA band 5.9 (17) 0.0 (2) 6.7 (15) NA NA
Truncus arteriosus
Repair 12.8 (102) 17.4 (23) 11.4 (79) 1.53 (0.52–4.51) .53
Tetralogy of Fallot
Primary repair 6.1 (99) 5.3 (19) 6.3 (80) 0.84 (0.10–6.79) .61
Shunt palliation 8.3 (97) 7.4 (27) 8.6 (70) 0.86 (0.19–4.02) .58
Interrupted arch
Repair 9.1 (110) 12.9 (31) 7.6 (79) 1.70 (0.51–5.61) .69
CI, Confidence interval; TGA/IVS, transposition of the great arteries/intact ventricular septum;ASO, atrial switch operation; TAPVC, total anomalous pulmonary
venous connection; PA/VSD, pulmonary atresia/ventricular septal defect; PA band, pulmonary artery band; TGA/VSD, transposition of the great arteries/
ventricular septal defect; PA/IVS, pulmonary atresia/intact ventricular septum; RVOT, right ventricular outflow tract; AVSD, atrioventricular septal defect.
*P value is adjusted for hospital identity. Confidence intervals were not calculated for nonsignificant categories.system and ABC scores. SAS Statistical software (Cary, NC) was
used for analysis.
Results
A total of 3022 patients were evaluated. In the group weigh-
ing 2.5 kg or more, there were a total of 517 patients, and in
the group weighing more than 2.5 to 4.0 kg, there were 2505
patients. The cardiac diagnoses of the groups are listed in
Table 1. There were no differences between sex, ethnicity,
or age between the groups (Table 2).
Patients undergoing repair of total anomalous pulmonary
venous connection (29.2% vs 9.9%), coarctation of the aorta
repair (7.1% vs 2.7%), arterial switch procedure for transpo-
sition of the great arteries (TGA; 11.8% vs 2.6%), systemic to548 The Journal of Thoracic and Cardiovascular Surgery c Marpulmonary artery shunt placement for pulmonary atresia with
ventricular septal defect (PA/VSD; 14.8% vs 2.8%), and sys-
temic to pulmonary artery shunt (24.4% vs 6.2%) and the
Norwood procedure (30% vs 21.1%) for other single-
ventricle diagnoses demonstrated increased risk of mortality
for those infants weighing 2.5 kg or more (Table 3). Patients
with PA/VSD and TGA with intact ventricular septum
weighing less than 2.5 kg had the highest risk ratios. For
all other diagnosis–procedure categories analyzed, there
was no statistically significant difference in mortality for
those infants weighing less than 2.5 kg. The inverse associa-
tion between infant weight and outcomes persisted after we
stratified the population using the RACHS-1 and ABC
scoring systems. Weight less than 2.5 kg was consistentlych 2008
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Dassociated with 1.5 to 3.0 times higher mortality risk in all
levels of RACHS-1 and ABC scoring, with the exception
of ABC level 1 (Table 4).
Discussion
Significant advances in surgical techniques and conduct of
cardiopulmonary bypass have resulted in improved survival
for even the smallest of patients. These advancements now
allow surgeons to routinely perform definitive open cardiac
procedures in neonates and infants weighing less than 2500
g. In the past, only palliative procedures or medical therapy
might have been available to such patients.
The New England Regional Infant Cardiac Program,7 as
well as Kramer and colleagues,8 demonstrated infants with
congenital heart disease (CHD) were more likely to be small
for gestational age or of low birth weight when compared
with normal-weight infants. The incidence of being small
for gestational age is 15% and that of low birth weight is
8.6% in infants with CHD compared with 4.5% and 6%, re-
spectively, in the healthy population. After adjusting for
other potential confounding factors, the New England Re-
gional Infant Cardiac Program concluded that there was a di-
rect relationship between mortality and birth weight of less
than 2 kg. They assigned a prognostic value from 1 (best)
to 4 (worst) in an attempt to risk stratify the various diagnoses
and then calculated crude 1-year mortality rates according to
these diagnostic severity groups, analyzing infants with
a birth weight of less than 2 kg as a group of interest. Calcu-
lated mortality rates in the less than 2-kg group ranged from
70% to 100% compared with 27% to 86% for the same diag-
nostic severity groups.7 Since that time, there have been mul-
tiple attempts to further examine the relationship between
birth weight and mortality for infants with CHD. However,
these studies have been limited to single institutions with lim-
ited numbers of patients or have examined weight as an inde-
TABLE 4. Mortality data by complexity scoring
Mortality rate,
1–2.5 kg
(n 5 517)
Mortality rate,
2.5–4 kg
(n 5 2505)
Risk ratio
(95% CI)
P
value
RACHS-1
2 5.0 (139) 2.4 (709) 2.1 (0.89–4.97) .03
3 14.2 (183) 5.6 (840) 2.5 (1.62–3.99) ,.01
4 21.9 (105) 9.7 (462) 2.3 (1.43–3.55) ,.01
6 30.0 (90) 21.1 (494) 1.4 (1.00–2.04) .03
Aristotle
1 80.0 (5) 26.7 (15) 3.0 (1.16–7.73) .32
2 11.7 (222) 5.5 (876) 2.1 (1.36–3.37) ,.01
3 13.6 (88) 5.2 (544) 2.7 (1.40–5.01) ,.01
4 20.78 (178) 13.6 (965) 1.5 (1.10–2.13) ,.01
Risk level
missing
16.7 (24) 1.9 (105) 8.75 (1.7–45.04) .08
RACHS-1, Risk Adjustment for Congenital Heart Surgery 1.The Journal of Thorpendent risk factorwithout careful case-control procedures.1-5
Analysis of the STS Congenital Heart Database affords the
opportunity to further examine these clinical questions with
sample sizes larger than has been previously possible.
The combination of low birth weight, prematurity, and
CHD makes the management of these patients challenging.
It is unclear whether a strategy of medical management and
deferment of surgical intervention is beneficial over more ex-
peditious intervention. Preoperative management of infants
with ductal-dependent pulmonary or systemic blood flow
requires intravenous prostaglandin E1 and carries the asso-
ciated risks of infection, apnea, vasodilation, seizures, and
necrotizing enterocolitis. Furthermore, the altered physio-
logic state of unrepaired CHD leads to increased energy ex-
penditure, failure to thrive, and further difficulty in weight
gain. The long-term effects of abnormal cardiovascular phys-
iology, including volume overload and hypoxemia, are diffi-
cult to quantify.9 Conventional surgical wisdom might
suggest that delaying surgical intervention until a higher
weight is attained might decrease the risk of bypass-related
morbidities, including intracranial hemorrhage, renal dys-
function, and coagulopathy. At the present time, however,
there are insufficient data to predict the risk/benefit ratio of
deferring surgical intervention until some arbitrary weight
gain. In a small series of patients, Chang and colleagues10
demonstrated not only that this management strategy was in-
effective but that in their experience it was associated with in-
creased mortality. In another single-institution study by
Reddy and associates,4 an analysis of approximately 100 in-
fants weighing less than 2.5 kg led to the inference that delay-
ing repair conferred higher preoperative morbidity without
any associated benefit. Unfortunately, given the limitations
of the present study, we are unable to adequately address
and answer the question of whether a strategy of deferring
surgical intervention for weight gain is beneficial. Further
prospective investigation to determine how the risk of delay-
ing surgical intervention on these patients compares with the
risk of repair is still necessary.
In this investigation we have demonstrated an increased
mortality associated with low-weight infants undergoing spe-
cific cardiovascular procedures for coarctation of the aorta,
total anomalous pulmonary venous connection, TGA, PA/
VSD, and the presence of a single ventricle. Roussin and co-
workers11 demonstrated similar findings, with operative mor-
tality of 16% in patients weighing less than 2000 g with TGA
undergoing the arterial switch operation. Overall operative
mortality in patients with hypoplastic left heart syndrome is
approximately 20%, whereas some investigations have
shown a mortality rate in low-weight patients to be as high
as 45%.12 In the present investigation the mortality rate for
low-weight patients undergoing a Norwood procedure was
30%. Findings in our study would suggest that there is a sub-
set of low-weight patients with increased risk of operative
mortality. At the same time, the data suggest that someacic and Cardiovascular Surgery c Volume 135, Number 3 549
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Dcardiovascular procedures can be performed without substan-
tial difference in mortality.
Both the ABC and RACHS-1 scoring systems were
designed to facilitate meaningful comparisons of outcomes
in children undergoing surgical intervention for CHD.6,13
Analysis of mortality based on either of these scoring systems
and stratified by weight has not previously been performed.
Mortality rates for nearly all infants of weight less than 2.5
kg is increased throughout the various levels of complexity,
as stratified by using both of these tools. The high absolute
mortality rates for both weight categories in ABC level 1
were not statistically significant and lack power for meaning-
ful interpretation of these data because of the small sample
sizes.
Further stratification within the diagnosis–procedure cate-
gories, as well as the RACHS-1 and ABC scores, by age at
the time of surgical intervention was not feasible because
of the small sample size of low-weight patients. For low-
weight patients undergoing a Norwood procedure, there
was a trend toward increased mortality for those who were
taken to surgical intervention within the first week of life.
However, within this age stratification, overall sample sizes
were too small to provide meaningful data.
The limitations of the study are primarily related to the
observational and voluntary nature of the database, which
is still in evolution. The STS databases are observational
and were established principally for the purpose of health
care quality improvement. We investigated the feasibility
of adjusting for potential confounding variables, such as pre-
operative risk factors and associated noncardiac anomalies.
Unfortunately, attempts at a multivariate analysis to examine
the interaction for these potential confounders were unsuc-
cessful because of a high percentage of missing data.
Also, it was not possible to determine whether some patients
had been operated on after a period of nonoperative manage-
ment or if there was any survival benefit to this approach.
Because the STS Congenital Database is a procedural data-
base, patients who did not survive to a surgical procedure are
not included. Many of the previous reports are based on
birth weight; however, at the time of the data harvest used
in our analysis, birth weight and gestational age were not
components of the data set, thereby making parallel compar-
isons difficult. Additionally, the inability to stratify by age
within both diagnosis–procedure and risk scoring made
analysis of the effect of delayed intervention with medical
management infeasible. Therefore this study cannot make
any conclusions or recommendations regarding any particu-
lar management strategy regarding low-birth-weight infants
with CHD.
Low weight at the time of surgical intervention is associ-
ated with increased mortality for repair of coarctation of the
aorta, total anomalous pulmonary venous connection, arterial
switch procedure for TGA, systemic to pulmonary artery
shunt placement for PA/VSD, and systemic to pulmonary550 The Journal of Thoracic and Cardiovascular Surgery c Maartery shunt and the Norwood procedure for single-ventricle
palliation. Notwithstanding several important limitations,
this study is nonetheless one of the largest to date to examine
the relationship between low birth weight and the risk of
operative mortality in congenital heart surgery. It highlights
the need for prospective analyses of specific treatment strat-
egies as a means of improving outcomes for these high-risk
patients.
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Discussion
Dr Scott M. Bradley (Charleston, SC). Chris, that was a very nice
and very clear presentation. I want to commend you as a cardiologist
for being willing to come and talk to a room full of surgeons. You
and your coauthors have brought to us a large and multi-institutional
examination of the effects of small patient size on the outcome of
congenital heart operations.
Your finding on mortality after shunt placement is interesting. If
one goes through your article and takes all of the patients weighing
less than 2.5 kg undergoing a shunt placement, other than aNorwood
procedure, hospital mortality was 18%, a fairly striking figure, if not
terribly surprising.rch 2008
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DFrom a practical standpoint, when we are confronted with a small
baby with CHD, we, as surgeons, have at least 2 questions:What op-
eration do we perform, and when do we perform it? In terms of tim-
ing, is it better to operate immediately or later, perhaps waiting for
growth, which generally does not occur? Because your data do
not include information on patients not undergoing operations,
they cannot help us with this question.
The first question, choice of operation, applies to patients who
can be either palliated or repaired. Therefore another interesting ob-
servation in your data is that if one looks at the patients who could
have had either a shunt or a complete repair, namely tetralogy with
either pulmonary stenosis or pulmonary atresia, when weight was
less than 2.5 kg, more patients had a shunt than complete repair;
however, those repaired actually had a slightly lower mortality
than the patients who were shunted. I realize that the patients in these
2 pathways are likely not comparable, but it does highlight the fact
that palliation in low-birth-weight infants does not necessarily carry
a lower early risk than complete repair.
I have 2 questions for you. The first regards prematurity, which
obviously covaries with low weight. This raises the question of
whether the increased risk that you describe is due to prematurity,
low birth weight, or the 2 factors in some interacting fashion. Do
your data allow you to address this question?
Dr Curzon. They do not. Unfortunately, at the time of our anal-
ysis, gestational age, and therefore getting into the question of pre-
maturity, is not a component within the STS database, and we were
therefore unable to adequately assess that question.
We did try and attempt to analyze age at the time of surgical in-
tervention as another confounder, or variable, to try and get the idea
of management strategies that would delay surgical intervention, but
we were unable to do this as well.
Dr Bradley.Do you, or maybe Dr Jacobs, know whether prema-
turity will be included in the future iterations of the STS database?
Dr Jacobs.Absolutely, it has already been added, and the trick is
getting it in the database and then getting everybody to fill it out.
Dr Bradley.My second question is more general. Your study is
basically a univariate analysis of the effect of patient weight on mor-
tality. You did break down patients on the basis of RACHS-1 andThe Journal of ThoABC criteria. But given the list of data that you provided in your
Methods section, would it have been possible for you and your co-
authors to conduct a multivariate analysis that might have shed more
light on other determinants of mortality and the relative importance
of low birth weight?
Dr Curzon. Thanks, Dr Bradley; that is a great question, which
we also attempted to address. We tried to conduct a multivariate
analysis on possible confounders for mortality with potential data
that should be contained within the STS database. Unfortunately,
there is a fairly large percentage of missing data when it comes to
preoperative risk factors, intraoperative complications, and postop-
erative complications, including things like ventilator management,
length of time on inotropic support, and things of that nature. Be-
cause of this significantly high percentage of missing data, it
made a multivariate analysis very difficult.
Dr Bradley. Therefore the issue is that the data fields exist, but
they have just been incompletely submitted?
Dr Curzon. Correct.
DrGrahamR. Nunn (Westmead, New South Wales, Australia).
I just noticed you did not include any premature ductus in this anal-
ysis, and I would be the first one to agree that they do not compare in
a cardiac corrective way to the lesions that you have described, but
they are a tool with which you can probe the prematurity issue quite
well because it is a curative operation in a similar age and weight
range. If we, as we will, find that the mortality there is 9% or 10%
with a similar weight, it does throw more light onto the other factors
that are involved in the more complex lesions that you are probing.
After all, they share the same precipitous delivery, with its potential
for cerebral trauma, and have the same immature lungs. They are
managed in the same intensive care unit with the same intensivist
and protocols and share the same cardiac anesthetic regimens and
postoperative care in the same institutions as their more complex
cardiac cousins.
Dr Curzon. That is an interesting idea. Thank you. We did ex-
clude isolated patent ductus arteriosus as a diagnosis, but that is an
interesting idea that you raise that could have helped us maybe with
some of the limitations with gestational age/prematurity within the
database.racic and Cardiovascular Surgery c Volume 135, Number 3 551
